TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7656888

Group type: EXPERIMENTAL
Intervention: High-amylose starch in starchy drinks and puddings
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Fat addition to starchy drinks, puddings, and rolls
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Guar gum addition to rolls
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Experimental foods as mid-morning snack
Number of subjects: 49
Study: 2699572

Group type: EXPERIMENTAL
Intervention: Multi-tufted short-head toothbrushes with different bristle bed designs
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Slanted bristle bed toothbrush
Number of subjects: 15
Study: 9689

Group type: EXPERIMENTAL
Intervention: epicillin
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: ampicillin
Number of subjects: 96
Study: 7361102

Group type: EXPERIMENTAL
Intervention: Food dye blend (100 or 150 milligrams)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 31779603

Group type: EXPERIMENTAL
Intervention: In-person training model
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Online training model
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 53
Study: 28703950

Group type: EXPERIMENTAL
Intervention: Internet-based psychoeducation treatment group (n = 40)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Internet-based control group with no psychoeducation (n = 40)
Number of subjects: 80
Study: 28186932

Group type: EXPERIMENTAL
Intervention: Optimised 1:1 physiotherapy outpatient intervention including education, advice, mobility and core stability exercises, progressive exercise, and encouragement of early return to work/activity (≤8 sessions for ≤8 weeks, starting 4 weeks post surgery)
Number of subjects: 29
Study: 25114907

Group type: EXPERIMENTAL
Intervention: Four-channel FES
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45

Group type: COMPARATOR
Intervention: Dual-channel
Number of subjects: 45
Study: 23348488

Group type: EXPERIMENTAL
Intervention: Ultrasound guidance
Number of subjects: 135

Group type: COMPARATOR
Intervention: Traditional method (without ultrasound)
Number of subjects: 135
Study: 19346328

Group type: EXPERIMENTAL
Intervention: Dopamine agonists
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control patients (without pathological gambling)
Number of subjects: 0
Study: 17488455

Group type: EXPERIMENTAL
Intervention: 5-fluorouracil (5-FU)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Mitomycin C (MMC)
Number of subjects: 40
Study: 15249317

Group type: EXPERIMENTAL
Intervention: Home based strength training with loads of 50‐70% of repetition maximum (EG)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Range of motion exercises (CG)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Home based strength training (EG)
Number of subjects: 70
Study: 12586138

Group type: EXPERIMENTAL
Intervention: Lepirudin
Number of subjects: 44

Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: CCP-aPTT
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: STA-aPTT
Number of subjects: 44
Study: 9723435

Group type: EXPERIMENTAL
Intervention: Rapamycin (RAPA)
Number of subjects: 250
Study: 8077371

Group type: EXPERIMENTAL
Intervention: GnRH at 3-h frequency (slow)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: GnRH every 45 min (fast)
Number of subjects: 8
Study: 2687586

Group type: EXPERIMENTAL
Intervention: Oral pilocarpine
Number of subjects: 0
Study: 778345

Group type: EXPERIMENTAL
Intervention: Chymopapain
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 31169571

Group type: EXPERIMENTAL
Intervention: Patellar tendon reconstruction
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: Hamstring tendon reconstruction
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: Double-bundle hamstring reconstruction
Number of subjects: 330
Study: 28430015

Group type: EXPERIMENTAL
Intervention: Mindfulness and acceptance group therapy
Number of subjects: 117

Group type: COMPARATOR
Intervention: Treatment-as-usual
Number of subjects: 117
Study: 25883989

Group type: EXPERIMENTAL
Intervention: Gamma-irradiated BCG vaccination
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 23521115

Group type: EXPERIMENTAL
Intervention: Advanced Practice Nurse Psychiatric Bridging Intervention
Number of subjects: 57

Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 57
Study: 21219596

Group type: EXPERIMENTAL
Intervention: RTMM including SMS reminders and personal webpage access
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: RTMM without SMS reminders or webpage access
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study: 19577160

Group type: EXPERIMENTAL
Intervention: Learning Virtual Object (LVO) for teaching radiographic cephalometry
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional teaching method (theory and practical classes)
Number of subjects: 40
Study: 17049236

Group type: EXPERIMENTAL
Intervention: Walking towards a goal without restrictions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Walking towards a goal with restrictions
Number of subjects: 0
Study: 15138428

Group type: EXPERIMENTAL
Intervention: Misoprostol (active drug)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 40
Study: 10623692

Group type: EXPERIMENTAL
Intervention: Filgrastim
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Filgrastim or sequential regimen
Number of subjects: 156

Group type: COMPARATOR
Intervention: Sargramostim
Number of subjects: 156
Study: 9369134

Group type: EXPERIMENTAL
Intervention: Etanidazole (Eta) with dose and schedule adjustment
Number of subjects: 521

Group type: COMPARATOR
Intervention: Conventional radiation therapy (RT) alone
Number of subjects: 521
Study: 1550277

Group type: EXPERIMENTAL
Intervention: Mandatory drinkers (n=464)
Number of subjects: 989

Group type: COMPARATOR
Intervention: Elective drinkers (n=525)
Number of subjects: 989
Study: 2412042

Group type: EXPERIMENTAL
Intervention: Ketanserin (40 mg b.i.d.)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Beta‐adrenergic blockers alone
Number of subjects: 10
Study: 31019383

Group type: EXPERIMENTAL
Intervention: VisualDx (intervention group)
Number of subjects: 433

Group type: COMPARATOR
Intervention: Control group (no VisualDx)
Number of subjects: 433
Study: 28065677

Group type: EXPERIMENTAL
Intervention: Integrated diabetes care program (DIAPREM) with quarterly clinical appointments
Number of subjects: 300

Group type: COMPARATOR
Intervention: Traditional care (Control group)
Number of subjects: 300
Study: 26214725

Group type: EXPERIMENTAL
Intervention: Riluzole 50 mg twice a day
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 24114221

Group type: EXPERIMENTAL
Intervention: Training reinforcement group (n = 42)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Abstinence and training reinforcement group (n = 43)
Number of subjects: 124

Group type: COMPARATOR
Intervention: No-reinforcement group (n = 39)
Number of subjects: 124
Study: 20850275

Group type: EXPERIMENTAL
Intervention: Galantamine up to 24mg/day
Number of subjects: 32
Study: 18487480

Group type: EXPERIMENTAL
Intervention: Fenofibrate 160 mg daily
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 200 mg daily
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Fenofibrate 160 mg plus CoQ 200 mg daily
Number of subjects: 74

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 74
Study: 16582861

Group type: EXPERIMENTAL
Intervention: Combined transoral odontoidectomy and occipito-cervical fusion
Number of subjects: 19
Study: 14768777

Group type: EXPERIMENTAL
Intervention: Non-specific, high-volume, low-intensity exercise training program (NET)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Individualised, low-volume and high-intensity exercise training program (IET)
Number of subjects: 90
Study: 10697397

Group type: EXPERIMENTAL
Intervention: Stem cell factor (SCF)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: CYFRA 21.1
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Carcinoembryonic antigen (CEA)
Number of subjects: 34
Study: 8931744

Group type: EXPERIMENTAL
Intervention: Cytarabine 500 mg/m2 0 h and 12 h, cisplatin 15 mg/m2 6 h and 18 h. Day 2‐4: cisplatin 30 mg/m2. Cycles repeated every 4 weeks
Number of subjects: 37
Study: 1880233

Group type: EXPERIMENTAL
Intervention: Estazolam 2 mg
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Flurazepam 30 mg
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Estazolam 1 mg
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Estazolam 2 mg and Flurazepam 30 mg
Number of subjects: 223

Group type: COMPARATOR
Intervention: Flurazepam
Number of subjects: 223

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 223
Study: 7068093

Group type: EXPERIMENTAL
Intervention: Combination of chlorhexidine, tramazoline and aluminiumtrilactate (n = 50)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Hexetidine (n = 49)
Number of subjects: 100
Study: 31173464

Group type: EXPERIMENTAL
Intervention: High-intensity focused ultrasound treatment
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control (untreated side)
Number of subjects: 25
Study: 31470879

Group type: EXPERIMENTAL
Intervention: Phlebotomy (450 mL of whole blood venesection)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Oral contraceptives (OCs) containing cyproterone acetate (3 months treatment)
Number of subjects: 64
Study: 27842470

Group type: EXPERIMENTAL
Intervention: Collaborative care intervention (delivered by social workers without previous mental health experience, including cognitive-behavioral therapy or facilitated antidepressant medication)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Collaborative care intervention
Number of subjects: 400

Group type: COMPARATOR
Intervention: Enhanced usual care (pamphlet about depression, letter for primary care provider, list of local mental health resources)
Number of subjects: 400
Study: 25985960

Group type: EXPERIMENTAL
Intervention: Decision Aid (DA) provided by a nurse containing information on adverse events, tumor response, and survival.
Number of subjects: 77

Group type: COMPARATOR
Intervention: Oncologists' judgment of patients' information desire.
Number of subjects: 77
Study: 24130097

Group type: EXPERIMENTAL
Intervention: Prostate cancer screening brochure for AA men + partner brochure with strategies
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Partner brochure
Number of subjects: 231

Group type: COMPARATOR
Intervention: Centers for Disease Control brochure only
Number of subjects: 231
Study: 21742514

Group type: EXPERIMENTAL
Intervention: Turmeric supplementation (500 mg turmeric, 22.1 mg curcumin, 3 capsules daily for 3 months)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo capsules (starch, identical in color and size to turmeric capsules, 3 capsules daily for 3 months)
Number of subjects: 24
Study: 19631845

Group type: EXPERIMENTAL
Intervention: Pulpotomy procedures
Number of subjects: 0
Study: 17492905

Group type: EXPERIMENTAL
Intervention: Preventive interventions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Treatment interventions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Preventive and therapeutic studies
Number of subjects: 0
Study: 15798291

Group type: EXPERIMENTAL
Intervention: R(int,mo) measured in normal adults
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: R(int,na) measured in normal adults
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: R(int,mo) measured in children
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: R(int,mo) measured in COPD patients
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: R(int) measured at fixed inspiratory flows
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: R(int) measured at flows <0.3 l s(‐1)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: R(int) measured at increasing flows
Number of subjects: 45
Study: 12939120

Group type: EXPERIMENTAL
Intervention: Chitosan formulation (2100 mg chitosan and 300 mg psyllium husk seeds, six capsules three times daily for three days)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 9583342

Group type: EXPERIMENTAL
Intervention: Preparing for the Drug‐Free Years Program (PDFY)
Number of subjects: 523

Group type: EXPERIMENTAL
Intervention: Iowa Strengthening Families Program (ISFP)
Number of subjects: 523

Group type: COMPARATOR
Intervention: Minimal-contact control group
Number of subjects: 523
Study: 10404421

Group type: EXPERIMENTAL
Intervention: Sour tea (Hibiscus sabdariffa)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 54
Study: 1854051

Group type: EXPERIMENTAL
Intervention: Adenosine triphosphate (ATP) at doses of 0.012, 0.025, and 0.05 mg.kg‐1.min‐1
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 6344732

Group type: EXPERIMENTAL
Intervention: Combination of subcuticular suture and sterile Micropore tape
Number of subjects: 169

Group type: COMPARATOR
Intervention: Conventional interrupted sutures
Number of subjects: 169
Study: 30876552

Group type: EXPERIMENTAL
Intervention: Cubist model
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Random Forest (RF) model
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Average Artificial Neural Network (avNNET) model
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Artificial Neural Network (nnet) model
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Partial Least Squares Regression (PLSR) model
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Consensus model
Number of subjects: 156
Study: 29870591

Group type: EXPERIMENTAL
Intervention: Amenamevir 400 mg with montelukast 10 mg
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Amenamevir 400 mg with bupropion 150 mg
Number of subjects: 48
Study: 26045008

Group type: EXPERIMENTAL
Intervention: Circumferential subcuticular wound approximation (CSWA)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Conventional wound closure
Number of subjects: 121
Study: 23720840

Group type: EXPERIMENTAL
Intervention: CF patients with carbohydrate metabolic disturbances (CMD)
Number of subjects: 350

Group type: COMPARATOR
Intervention: CF patients without CMD
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: CF patients with impaired glucose tolerance (IGT)
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: CF patients with CF-dependent diabetes mellitus (CFDDM)
Number of subjects: 350
Study: 21194357

Group type: EXPERIMENTAL
Intervention: Sitagliptin (DPPIV inhibitor)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 18651257

Group type: EXPERIMENTAL
Intervention: MR arthrography with Gd-DTPA2- injection and comprehensive imaging (static and dynamic)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Static MR imaging
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Dynamic motion MR imaging
Number of subjects: 23
Study: 17050788

Group type: EXPERIMENTAL
Intervention: Varenicline 1 mg once daily for 7 days (n = 8)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Varenicline 1 mg twice daily for 6 days with a single dose on day 7 (n = 8)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (n = 4)
Number of subjects: 24
Study: 15727187

Group type: EXPERIMENTAL
Intervention: Multiplex nutritional intervention group (100 g coarse food grain every day and nutrition education)
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Simplex nutritional intervention group (only nutrition education)
Number of subjects: 260

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 260
Study: 11004017

Group type: EXPERIMENTAL
Intervention: L-arginine (30 g over 30 min)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: GHRP-2 (1 microg/kg bolus)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Combination of L-arginine and GHRP-2 (AG)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Saline (S)
Number of subjects: 18
Study: 9006223

Group type: EXPERIMENTAL
Intervention: New visual agenda-setting technology and other visual aids applied using negotiation and motivational interviewing
Number of subjects: 200
Study: 1346342

Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control (triple therapy without amiodarone)
Number of subjects: 63
Study: 6088192

Group type: EXPERIMENTAL
Intervention: Diet A (41% carbohydrates, 41% fat)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Diet B (60% carbohydrates, 20% fat)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Standard meal with 12 g olive oil
Number of subjects: 6

Group type: COMPARATOR
Intervention: Standard meal with 36 g olive oil
Number of subjects: 6
Study: 29101120

Group type: EXPERIMENTAL
Intervention: VOICES-SF questionnaire
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pilot study methods
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Retrospective mortality follow-back method
Number of subjects: 0
Study: 29427024

Group type: EXPERIMENTAL
Intervention: linagliptin (5 mg, once-daily)
Number of subjects: 16

Group type: COMPARATOR
Intervention: voglibose (0.9 mg, thrice-daily)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: linagliptin
Number of subjects: 16
Study: 27009045

Group type: EXPERIMENTAL
Intervention: Enhanced invitation letter using insights from behavioural science
Number of subjects: 3511

Group type: COMPARATOR
Intervention: Standard national invitation template letter
Number of subjects: 3511
Study: 25042737

Group type: EXPERIMENTAL
Intervention: A‐LMR ≥ 1.0 in the training set
Number of subjects: 379

Group type: COMPARATOR
Intervention: A‐LMR < 1.0 in the training set
Number of subjects: 379

Group type: EXPERIMENTAL
Intervention: A‐LMR ≥ 1 in the validation set
Number of subjects: 379

Group type: COMPARATOR
Intervention: A‐LMR < 1 in the validation set
Number of subjects: 379
Study: 22753863

Group type: EXPERIMENTAL
Intervention: 1×60 min a week of supervised high‐intensity strength training for 20 weeks
Number of subjects: 447

Group type: EXPERIMENTAL
Intervention: 3×20 min a week of supervised high‐intensity strength training for 20 weeks
Number of subjects: 447

Group type: EXPERIMENTAL
Intervention: 9×7 min a week of supervised high‐intensity strength training for 20 weeks
Number of subjects: 447

Group type: COMPARATOR
Intervention: Reference group without training (REF)
Number of subjects: 447
Study: 20965305

Group type: EXPERIMENTAL
Intervention: Complex PD group
Number of subjects: 134

Group type: COMPARATOR
Intervention: No PD, personality difficulty, simple PD groups
Number of subjects: 134
Study: 16784903

Group type: EXPERIMENTAL
Intervention: Multiple micronutrients (ML1)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 16332235

Group type: EXPERIMENTAL
Intervention: EMD + NBM
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: EMD + beta‐TCP
Number of subjects: 24
Study: 12149667

Group type: EXPERIMENTAL
Intervention: Trandolapril (2 mg/day)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Irbesartan (300 mg/day)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Combined therapy (Trandolapril 0.5 mg/day + Irbesartan 150 mg/day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 9539500

Group type: EXPERIMENTAL
Intervention: Abciximab (platelet glycoprotein IIb/IIIa inhibitor)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard therapy (control group not explicitly mentioned)
Number of subjects: 0
Study: 15490780

Group type: EXPERIMENTAL
Intervention: Composite resin (Tetric)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Conventional glass ionomer cement (Ketac Fil)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Final restorations (ceramic inlays - Empress)
Number of subjects: 12
Study: 2618843

Group type: EXPERIMENTAL
Intervention: Attention-placebo (information based) smoking prevention program
Number of subjects: 14

Group type: COMPARATOR
Intervention: Experimental social influences program
Number of subjects: 14
Study: 337478

Group type: EXPERIMENTAL
Intervention: Intravenous administration of glycerol (25 g twice daily for 6 days)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo infusions
Number of subjects: 26
Study: 30779861

Group type: EXPERIMENTAL
Intervention: High-intensity Fracture Liaison Service (FLS) Case-Manager intervention
Number of subjects: 361

Group type: COMPARATOR
Intervention: Low-intensity FLS (Active Control)
Number of subjects: 361

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 361
Study: 28932387

Group type: EXPERIMENTAL
Intervention: House dust mite provocations
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Grass pollen provocations
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Birch pollen provocations
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Allergen or pollen concentrations
Number of subjects: 86

Group type: COMPARATOR
Intervention: Baseline PNIF
Number of subjects: 86
Study: 26115386

Group type: EXPERIMENTAL
Intervention: Structured physical activity
Number of subjects: 1635

Group type: COMPARATOR
Intervention: Health education
Number of subjects: 1635
Study: 23499068

Group type: EXPERIMENTAL
Intervention: Acrysof SA60AT (1‐piece IOL group)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sensar AR40e (3‐piece IOL group)
Number of subjects: 80
Study: 21684508

Group type: EXPERIMENTAL
Intervention: Aspirin 50 mg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Aspirin 100 mg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Aspirin 50 mg or 100 mg
Number of subjects: 100
Study: 19015284

Group type: EXPERIMENTAL
Intervention: Written descriptions plus photographs of patients with SSc
Number of subjects: 213

Group type: COMPARATOR
Intervention: Written descriptions only
Number of subjects: 213
Study: 16953009

Group type: COMPARATOR
Intervention: Iowa Strengthening Families Program (ISFP)
Number of subjects: 1236

Group type: COMPARATOR
Intervention: SFP 10-14 + Life Skills Training (LST)
Number of subjects: 1236

Group type: COMPARATOR
Intervention: LST alone
Number of subjects: 1236
Study: 15235301

Group type: EXPERIMENTAL
Intervention: Supervised treadmill exercise training
Number of subjects: 32

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 32
Study: 11334905

Group type: EXPERIMENTAL
Intervention: 5% saline infusion on day 3 or 4 after hCG administration in IVF patients
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 5% saline infusion test on day 10 after hCG administration
Number of subjects: 13

Group type: COMPARATOR
Intervention: 5% saline infusion in controls (normal menstrual cycles)
Number of subjects: 13